AstraZeneca seeks US FDA approval for COVID-19 preventive antibody drug
The AstraZeneca antibody drug, AZD7442 could protect individuals from developing symptomatic COVID-19. Vaccination remains the most effective way to prevent ...
Read moreThe AstraZeneca antibody drug, AZD7442 could protect individuals from developing symptomatic COVID-19. Vaccination remains the most effective way to prevent ...
Read moreAn important factor in achieving herd immunity against SARS-CoV-2 (the virus that causes COVID-19) is how long the vaccines protect ...
Read morePeople aged 16 and above will soon be able to get a COVID vaccine in Australia, but this begs the ...
Read moreIf you are 18 or older, and in an area where there is a COVID-19 outbreak, the best vaccine for ...
Read morePrime Minister Scott Morrison appeared to have made a “captain’s call” yesterday by encouraging people in New South Wales outbreak ...
Read moreIt has been a wild week for public messaging about the AstraZeneca COVID-19 vaccine — baffling both for the public ...
Read moreOn Monday night, Prime Minister Scott Morrison announced a new vaccine indemnity scheme. An indemnity scheme would mean health practitioners ...
Read moreThe new, modified vaccine from AstraZeneca and the University of Oxford will serve as a booster for protection against the ...
Read moreAustralia’s current crop of COVID-19 vaccines consists of a shot by American biotechnology company Pfizer, which we import, and the ...
Read moreAlongside logistical and supply issues, vaccine hesitancy has been a notable hurdle in Australia’s troubled vaccine rollout. The news the ...
Read moreAs a news and media company, our focus is on bringing you the latest news and information from the blockchain, gaming, technology, entertainment, and business industries.
Before reading any material on this website, it is a requirement to read “Terms and Conditions” and “Privacy Policy“ first. By reading or interacting with any of our content, website or social media you agree to be bound by these. This includes, but not limited to the public, consumers, readers & advertisers. Micky is a news site and does not provide trading, investing, or other financial advice. By using this website, you affirm that you have read and agree to abide by our Terms and Conditions